Abstract
Purpose
High blood glucose levels may decrease the sensitivity of 2-deoxy-2-[F-18]fluoro-d-glucose (FDG)-positron emission tomography (PET). The goal of this study was to assess whether intravenous (i.v.) insulin followed by FDG injection 60 minutes later could decrease the blood glucose level of hyperglycemic patients without altering muscular, liver, or lung FDG uptake.
Methods
We evaluated 53 diabetic patients with a fasting glycemia higher than 7.0 mmol/l. The control group consisted of 53 nondiabetic patients with a normal fasting glycemia. Sixty minutes before FDG injection, all diabetic patients received up to two intravenous bolus of insulin. Regions of interest were drawn over the lungs, heart, liver, skeletal muscles, and over the most active lung nodule, if present, to calculate a standardized uptake value (SUV) normalized to the lean body weight.
Results
After one or two boluses of insulin (mean 3.4 units), 39 diabetic patients decreased their blood glucose level from 9.4 ± 1.8 to 6.1 ± 1.3 mmol/l. In 14 patients, two doses of insulin (mean 4.5 ± 2.3 units) were not sufficient, but managed to decrease the blood glucose level from 10.6 ± 2.1 to 9.1 ± 2.1 mmol/l. There was no significant difference for the SUV calculated on the lung, liver, heart, and skeletal muscles. No differences were noted in lung tumor uptake in patients who received insulin compared to the control group.
Conclusions
With a sufficient waiting period between the insulin and FDG injections, an i.v. bolus of insulin makes it possible to effectively decrease glycemia of diabetic patients without increasing muscular FDG uptake.
Similar content being viewed by others
References
Hustinx R, Benard F, Alavi A (2002) Whole-body FDG-PET imaging in the management of patients with cancer. Semin Nucl Med 32(1):35–46
Diederichs CG, Staib L, Glatting G, et al. (1998) FDG-PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med 39(6):1030–1033
Lindholm P, Minn H, Leskinen-Kallio S, et al. (1993) Influence of the blood glucose concentration on FDG uptake in cancer—a PET study. J Nucl Med 34(1):1–6
Torizuka T, Fisher SJ, Brown RS, et al. (1998) Effect of insulin on uptake of FDG by experimental mammary carcinoma in diabetic rats. Radiology 208(2):499–504
Wahl RL, Henry CA, Ethier SP (1992) Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-d-glucose in rodents with mammary carcinoma. Radiology 183(3):643–647
Lewis P, Nunan T, Dynes A, et al. (1996) The use of low-dose intravenous insulin in clinical myocardial F-18 FDG-PET scanning. Clin Nucl Med 21(1):15–18
Sherwin RS, Kramer KJ, Tobin JD, et al. (1974) A model of the kinetics of insulin in man. J Clin Invest 53(5):1481–1492
Morgan DJ, Bray KM (1994) Lean body mass as a predictor of drug dosage. Implications for drug therapy. Clin Pharmacokinet 26(4):292–307
Medina RA, Owen GI (2002) Glucose transporters: expression, regulation and cancer. Biol Res 35(1):9–26
Marom EM, Aloia TA, Moore MB, et al. (2001) Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer. Lung Cancer 33(2–3):99–107
Langen KJ, Braun U, Rota Kops E, et al. (1993) The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 34(3):355–359
Crippa F, Gavazzi C, Bozzetti F, et al. (1997) The influence of blood glucose levels on [18F]fluorodeoxyglucose (FDG) uptake in cancer: a PET study in liver metastases from colorectal carcinomas. Tumori 83(4):748–752
Torizuka T, Zasadny KR, Wahl RL (1999) Diabetes decreases FDG accumulation in primary lung cancer. Clin Positron Imaging 2(5):281–287
Gorenberg M, Hallett WA, O’Doherty MJ (2002) Does diabetes affect [(18)F]FDG standardised uptake values in lung cancer? Eur J Nucl Med Mol Imaging 29(10):1324–1327
Chang YC, Yen TC, Ng KK, et al. (2005) Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer? Eur J Nucl Med Mol Imaging 32(6):647–652
Torizuka T, Fisher SJ, Wahl RL (1997) Insulin-induced hypoglycemia decreases uptake of 2-[F-18]fluoro-2-deoxy-d-glucose into experimental mammary carcinoma. Radiology 203(1):169–172
Zhao S, Kuge Y, Tsukamoto E, et al. (2001) Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions. Eur J Nucl Med 28(6):730–735
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Turcotte, E., Leblanc, M., Carpentier, A. et al. Optimization of Whole-Body Positron Emission Tomography Imaging by Using Delayed 2-Deoxy-2-[F-18]fluoro-d-glucose Injection Following I.V. Insulin in Diabetic Patients. Mol Imaging Biol 8, 348–354 (2006). https://doi.org/10.1007/s11307-006-0064-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-006-0064-1